Disruptive Changes for a Better Clinical Research Future
While the SARS-CoV-2 (COVID-19) pandemic has been terrible in terms of morbidity and mortality, it did show the promise of…
Frenova Empowers Investigators and Research Teams
Why Frenova? As a Fresenius Medical Care company, Frenova manages the world’s largest network of renal research assets: over 550…
Increase Revenue and Give Patients More Options With Clinical Trials: Five Things to Consider When Adding or Expanding Research at Your Practice
Adding clinical research is a business strategy that, if approached knowledgably, can be of great benefit to physicians and medical…
How Do You Keep Your Trials Moving Forward When Patients Can’t Come to Your Office? FRENOVA KNOWS
Learn how Frenova is helping sites continue clinical research during the COVID-19 pandemic.
How Do You Keep Studies Progressing When The World Stands Still?
Learn what Frenova has been doing to keep studies on track during the COVID-19 pandemic.
Protocol Design Trends Investigators Should Look for When Selecting Studies
For investigative sites, selecting studies for increased patient centricity, whether through decentralized trials, patient input in study design, or remote…
Building a Global Research Network: Chronic Kidney Disease as a Public Health Crisis
At least 20% of people aged 65 to 74, and 50% of people over 75, have chronic kidney disease. However,…
Missed Revenue in Clinical Research: 1 Study, 10 Sites, $154,000 Caught
Whether from faulty sponsor payment systems, incomplete invoicing, or other causes, private practice investigational sites routinely miss out on significant…
Access to Patients = Exceeded Enrollment
See how Frenova’s clinical research sites, through rapid startup, leveraged relationships and site management achieved enrollment goals in less time…
Chronic Kidney Disease Expertise
Success in chronic kidney disease clinical trials requires collaboration and close relationships with investigators who understand and provide care to…